Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577K Buy
1,594
+475
+42% +$163K 0.31% 80
2026
Q1
$394K Sell
1,119
-26,121
-96% -$9.31M 0.3% 78
2025
Q4
$345K Buy
27,240
+25,742
+1,718% +$8.17M 0.27% 79
2025
Q3
$423K Buy
1,498
+500
+50% +$145K 0.4% 71
2025
Q2
$279K Sell
998
-235
-19% -$66.6K 0.33% 82
2025
Q1
$382K Buy
1,233
+27
+2% +$7.97K 0.46% 64
2024
Q4
$314K Buy
+1,206
New +$358K 0.44% 66

Other funds holding AMGN

BXM Wealth's AMGN Position: Q2 2026 in Review

BXM Wealth increased its Amgen (AMGN) stake by 42% in Q2 2026, buying an estimated $163K and bringing the position to 1,594 shares worth $577K. The position accounts for 0.31% of the portfolio, ranked #80.

BXM Wealth first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,131 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • BXM Wealth held 1,594 shares of Amgen worth $577K as of Q2 2026.
  • BXM Wealth bought 475 Amgen shares in Q2 2026, an estimated $163K.
  • Amgen made up 0.31% of BXM Wealth's portfolio in Q2 2026, its #80 holding.
  • BXM Wealth first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,131 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BXM Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.